Alibaba Health Information Technology Ltd

00241

Company Profile

  • Business description

    Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer”, although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

  • Contact

    Guanghua Road
    65th Floor, CITIC Tower, Building 1, No.10 Courtyard
    Jianwai Subdistrict, Chaoyang District
    Beijing
    CHN

    https://www.alihealth.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    1,422

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,704.40143.20-1.82%
CAC 407,017.50257.45-3.54%
DAX 4020,010.11631.61-3.06%
Dow JONES (US)37,822.402,723.53-6.72%
FTSE 1007,802.51252.47-3.13%
HKSE19,812.033,037.78-13.29%
NASDAQ15,603.26947.34-5.72%
Nikkei 22532,952.65827.93-2.45%
NZX 50 Index11,891.44333.84-2.73%
S&P 5005,041.9432.14-0.63%
S&P/ASX 2007,510.00157.80-2.06%
SSE Composite Index3,109.6913.120.42%

Market Movers